30-day morbidity and mortality of revisional bariatric surgery - An international multi-centre collaborative (BROAD) study.

Autor: Nasta AM; Wockhardt Hospitals, Mumbai, India. Electronic address: amritnasta@hotmail.com., Goel R; Center for metabolic Surgery, Wockhardt Hospitals, Mumbai, India. Electronic address: ramengoel@gmail.com., Singhal R; University Hospitals Birmingham NHS Trust (1), Healthier Weight (2), Birmingham, United Kingdom. Electronic address: drrishisinghal@gmail.com., Lemmens L; AZ RIVIERENLAND, Bornem, Belgium. Electronic address: luc@dr-lemmens.be., Baig S; Digestive Surgery Clinic, Belle Vue Clinic, Kolkata, India. Electronic address: docsarfarazbaig2@gmail.com., Seki Y; Yotsuya Medical Cube, Tokyo, Japan. Electronic address: y-seki@mcube.jp., Prasad A; Indraprastha Apollo Hospital, New Delhi, India. Electronic address: surgerytimes@gmail.com., Chiappetta S; head obesity and metabolic surgery unit, Ospedale Evangelico Betania, Naples, Italy. Electronic address: drschiappetta@gmail.com., Kermansaravi M; Iran University of Medical Sciences, Iran. Electronic address: mkermansaravi@yahoo.com., Vertruyen M; Europe clinics of Brussels, Brussels, Belgium. Electronic address: marcvertruyen@skynet.be., Pascotto B; Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. Electronic address: ben.pascotto@gmail.com., Azagra JS; Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg. Electronic address: Azagra.js@chl.lu., Al-Khyatt W; East Midland Bariatric & Metabolic Institute (EMBMI), Derby, United Kingdom. Electronic address: waleed.al-khyatt@nhs.net., Martines G; Azienda Ospedaliero Universitaria Policlinico, Bari, Italy. Electronic address: gennaromartines@gmail.com., Villao DY; Clinica Vespucio, Santiago, Chile. Electronic address: divavillao@gmail.com., Revello L; Clinica Vespucio, Santiago, Chile. Electronic address: revelloch@gmail.com., Rioseco M; Clinica Vespucio, Santiago, Chile. Electronic address: mriosecov@gmail.com., Martini F; Clinique des Cedres, Cornebarrieu, France. Electronic address: framartini77@hotmail.com., Liagre A; Clinique des Cedres, Cornebarrieu, France. Electronic address: arnaud.liagre@orange.fr., Juglard G; Clinique des Cedres, Cornebarrieu, France. Electronic address: drjuglard@orange.fr., Dapri G; Head of Minimally Invasive General & Oncologic Surgery Center, Humanitas Gavazzeni University Hospital, Bergamo, Italy. Electronic address: giovanni@dapri.net., Proczko-Stepaniak MA; Medical University of Gdansk, Poland. Electronic address: mproczko@gumed.edu.pl., Abou-Mrad AK; Centre Hospitalier Regional d'ORLEANS, ORLEANS, France. Electronic address: adel.abou-mrad@orange.fr., Elghadban HM; Mansoura University, Eldakahlia, Egypt. Electronic address: drhelghadban@mans.edu.eg., Stier C; Interdisciplinary Endoscopy University hospital Mannheim., Germany. Electronic address: christinestier@gmail.com., Van Herck JLE; Abdominal and bariatric surgery, AZ Rivierenland, Antwerp, Belgium. Electronic address: jasper@drvanherck.com., Taha SA; Abu Dhabi, UAE. Electronic address: Safwan.Taha@Mediclinic.ae., Şen O; Nisantasi University/Türkçapar Bariatrics, İstanbul, Turkey. Electronic address: ozansen77@gmail.com., Dillemans B; AZ Sint Jan, Brugge, Belgium. Electronic address: bruno.dillemans@azsintjan.be., Van Hoef S; AZ Sint Jan, Brugge, Belgium. Electronic address: stijnvanhoef@gmail.com., Vandeputte M; AZ Sint Jan, Brugge, Belgium. Electronic address: mathieu.vandeputte@azsintjan.be., Viskens S; AZ Sint Jan, Brugge, Belgium. Electronic address: sofie.viskens@gmail.com., Gentileschi P; Department of Bariatric and Metabolic Surgery, San Carlo of Nancy Hospital and University of Rome Tor Vergata, ROME, ITALY. Electronic address: gentileschi.paolo@gmail.com., Palaniappan R; Apollo Hospitals, chennai, india. Electronic address: docraj@me.com., Sakran N; Faculty of medicine, Bar-Ilan University, Holy Family Hospital, Nazareth, Israel. Electronic address: sakranas@gmail.com., Shin TH; Cleveland Clinic Foundation, Cleveland, OH, United States. Electronic address: thshin@bwh.harvard.edu., Aminian A; Cleveland Clinic Foundation, Cleveland, OH, United States. Electronic address: aminiaa@ccf.org., Uccelli M; San Marco Hospital GSD, Zingonia (BG), Italy. Electronic address: matteo.uccelli@gmail.com., Olmi S; San Marco Hospital GSD, Zingonia (BG), Italy. Electronic address: stefano.olmi@gmail.com., Cesana GC; San Marco Hospital GSD, Zingonia (BG), Italy. Electronic address: giovanni.cesana@gmail.com., Anselmino M; San Marco Hospital GSD, Zingonia (BG), Italy. Electronic address: m.anselmino@me.com., Debergh NPA; CHC Montlégia, Liège, Belgium. Electronic address: nicolas.debergh@chc.be., Gärtner D; Head of the Obesity Center, Obesity Center Karlsruhe, Karlsruhe, Germany. Electronic address: daniel.gaertner@klinikum-karlsruhe.de., Yang W; The First Affiliated Hospital of Jinan University, Guangzhou, China. Electronic address: yangwah@qq.com., Bedi DS; Hope Obesity Centre, Ahmedabad, India. Electronic address: dbedi72@gmail.com., Mahawar K; South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK. Electronic address: kmahawar@gmail.com.
Jazyk: angličtina
Zdroj: Obesity research & clinical practice [Obes Res Clin Pract] 2024 May-Jun; Vol. 18 (3), pp. 195-200. Date of Electronic Publication: 2024 Jul 01.
DOI: 10.1016/j.orcp.2024.06.001
Abstrakt: Introduction: Revisional bariatric surgery (RBS) for insufficient weight loss/weight regain or metabolic relapse is increasing worldwide. There is currently no large multinational, prospective data on 30-day morbidity and mortality of RBS. In this study, we aimed to evaluate the 30-day morbidity and mortality of RBS at participating centres.
Methods: An international steering group was formed to oversee the study. The steering group members invited bariatric surgeons worldwide to participate in this study. Ethical approval was obtained at the lead centre. Data were collected prospectively on all consecutive RBS patients operated between 15th May 2021 to 31st December 2021. Revisions for complications were excluded.
Results: A total of 65 global centres submitted data on 750 patients. Sleeve gastrectomy (n = 369, 49.2 %) was the most common primary surgery for which revision was performed. Revisional procedures performed included Roux-en-Y gastric bypass (RYGB) in 41.1 % (n = 308) patients, One anastomosis gastric bypass (OAGB) in 19.3 % (n = 145), Sleeve Gastrectomy (SG) in 16.7 % (n = 125) and other procedures in 22.9 % (n = 172) patients. Indications for revision included weight regain in 615(81.8 %) patients, inadequate weight loss in 127(16.9 %), inadequate diabetes control in 47(6.3 %) and diabetes relapse in 27(3.6 %). 30-day complications were seen in 80(10.7 %) patients. Forty-nine (6.5 %) complications were Clavien Dindo grade 3 or higher. Two patients (0.3 %) died within 30 days of RBS.
Conclusion: RBS for insufficient weight loss/weight regain or metabolic relapse is associated with 10.7 % morbidity and 0.3 % mortality. Sleeve gastrectomy is the most common primary procedure to undergo revisional bariatric surgery, while Roux-en-Y gastric bypass is the most commonly performed revision.
Competing Interests: Declaration of Competing Interest All authors declare that they have no conflict of interest related to the study.
(Copyright © 2024. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: